Valeant Pharmaceuticals International Inc (NYSE:VRX)

223.02
Delayed Data
As of May 01
 +6.09 / +2.81%
Today’s Change
106.00
Today|||52-Week Range
227.76
+55.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues1.9B2.0B2.1B2.3B
 
 
 
 
 
Cost of Goods Sold472.5M543.5M514.6M537.1M
 
 
 
 
 
Depreciation And Amortization401.1M407.7M406.9M434.3M
 
 
 
 
 
 
Operating ExpensesGross Income1.0B1.1B1.1B1.3B
 
 
 
 
 
General Expenses543.3M582.2M563.2M583.6M
 
 
 
 
 
Research And Development61.3M66.5M59.1M59.1M
 
 
 
 
 
Total Operating Expenses1.4B1.5B1.5B1.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income469.3M507.7M571.5M725.0M
 
 
 
 
 
Extraordinary Credit------28.9M
 
 
Extraordinary Charge-249.7M-153.0M-140.0M-138.7M
 
 
 
 
 
Interest Expense On Debt246.5M241.2M258.4M223.7M
 
 
 
 
 
Other Expenses29.9M6.3M202.8M198.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.8M121.0M376.7M590.1M
 
 
 
 
 
Income Taxes-25.1M-1.0M-100.3M-56.0M
 
 
 
 
 
Minority Interest-2.3M-3.8M-1.0M-800.0K
 
 
 
 
 
Net Income-22.6M125.8M275.4M534.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS334.9M335.3M335.4M335.8M
 
 
 
 
 
Shares To Calculate EPS Diluted334.9M341.3M341.3M341.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07$0.38$0.82$1.59
 
 
 
 
 
EPS Diluted-$0.07$0.37$0.81$1.56
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account